The Health Investigation Center in Manhica, also known as CSIM, published, on Wednesday 17 October 2007, results of a product that could lead to a vaccine against malaria.
Results reveal a 65% reduction of new infections in newborn babies aged between 10 to 18 weeks for a period of 3 months following treatment.
In addition, these children had a 35% reduction in "cyclic episodes of malaria" 6 months after starting treatment.
Dr. Pedro Luis Alonso, Scientific Director of the Manhiça Health Research Center (pictured left) says that if results continue to be positive, "Phase III" will start in the second half of next year". Successful results in "Phase III" could lead to the submission of the vaccine to the regulatory authorities in 2011.
0 click here to comment:
Post a Comment